Q2 profit falls 36% as revenue declines; half-year sales rise 7%
PAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Q2 revenue from operations fell 4.3% year on year to Rs 27.43 crore, while profit after tax dropped 36.4% to Rs 2.63 crore and EPS was Rs 2.14. For the half year, revenue rose 7.3% to Rs 58.71 crore, but profit after tax eased 1.6% to Rs 7.34 crore. Operating cash flow was positive at Rs 2.34 crore.
Q2 profit and margins fell sharply, creating near-term pressure, though half-year sales grew, cash flow stayed positive and borrowings were nil.